These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1029992)

  • 1. [Long-term treatment of essential hypertension using a beta-receptor blockader: effect on total-body-potassium and exchangeable sodium].
    Brecht HM; Werner E; Vlachoyannis J; Bechstein PB; Schoeppe W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1329-32. PubMed ID: 1029992
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension].
    Klein WW; Brandt D; Fluch N; Goebel R; Holzer H; Pöch G
    Adv Clin Pharmacol; 1976; 11():79-85. PubMed ID: 1032573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term therapy of essential hypertension with indapamide: studies on the effect on electrolyte balance and glucose metabolism].
    Zorn J
    Fortschr Med; 1980 Dec; 98(46):1836-40. PubMed ID: 7274922
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
    J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of pindolol on plasma renin activity in patients with essential hypertension.
    Tényi I; Németh M; Jávor T; Nemes J; Czimer J
    Eur J Clin Invest; 1977 Oct; 7(5):325-9. PubMed ID: 411662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolonged antihypertensive effect of beta-adrenolytic treatment with Visken in patients with essential hypertension].
    Lukasik S; Halawa B; Surowiak M; Kasprzak J
    Pol Tyg Lek; 1977 Nov; 32(47):1837-9. PubMed ID: 341096
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Adv Clin Pharmacol; 1976; 11():66-9. PubMed ID: 1032572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of essential hypertension with pindolol].
    Kocemba J; Kawecka-Jaszcz K; Sniezek M; Starzycka M; Augustyński W
    Kardiol Pol; 1978; 21(3):201-8. PubMed ID: 691928
    [No Abstract]   [Full Text] [Related]  

  • 11. Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():551s-554s. PubMed ID: 1071679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long term study (1 year) with a beta receptor blocker-diuretic combination in hypertension treatment].
    Gotzen R; Faupel RP; Hammerschmidt D
    Med Welt; 1981 Sep; 32(39):1450-2. PubMed ID: 7029197
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
    Med J Aust; 1989 Jun; 150(11):646, 648, 651-2. PubMed ID: 2657348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
    Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
    Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of hypothiazide and reserpine on the intracellular and extracellular potassium and sodium correlation during the treatment of hypertensive disease].
    Gnedkova GL; Lazareva DN
    Ter Arkh; 1971 Mar; 43(3):37-40. PubMed ID: 5561193
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical test of a new beta-receptor blockader in labile hypertension].
    Walter I; Kusus T; Lydtin H
    Verh Dtsch Ges Inn Med; 1971; 77():940-3. PubMed ID: 5156091
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA; Iverson MT
    Arq Bras Cardiol; 1984 Jun; 42(6):435-41. PubMed ID: 6393921
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of treatment with propranolol or pindolol on the left ventricular myocardium mass in patients with slight essential arterial hypertension].
    Haczyński J; Spring A
    Wiad Lek; 1993 Apr; 46(7-8):241-4. PubMed ID: 8249408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.